Optum Ventures
VC Fund
Boston, United States
Optum Ventures is a VC fund in Boston focused on Health Care and Medical. Optum Ventures provides capital and strategic guidance to startup companies solving health care's pressing challenges. It is the venture capital investment arm of Optum that invests in digital health companies that use data and insights to help improve consumers' access to health care services and how care is delivered and paid for, andthat makes the health care system more reliable and easier to navigate.
- Total investments:
- 119
- Last investment:
- Lead investor:
- 30%
- Fund size:
- $250M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Optum Ventures invests in
Stages Optum Ventures invests in
Countries Optum Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $8M–$38M
- Series B
- $15M–$67M
- Series C
- $25M–$140M
Investment Focus
Industry
- Health Care 56 (47%)
- Medical 22 (18%)
- Wellness 14 (12%)
- Artificial Intelligence 13 (11%)
- Software 11 (9%)
Stage
- Series A 33 (28%)
- Series B 29 (24%)
- Series C 20 (17%)
- Series D 6 (5%)
- Venture - Series Unknown 6 (5%)
Country
- United States 56 (47%)
- United Kingdom 4 (3%)
- India 1 (1%)
- Belgium 1 (1%)
- Singapore 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Richie Chaikof
Principal
|
Principal | Total investments: 0 | Find email | |
Alessandro Guazzi
Healthcare Venture Capital
|
Healthcare Venture Capital | Total investments: 0 | Find email | |
Heather Roxborough
Partner
|
Partner | Total investments: 9 | Find email | |
Vijay Barathan
Senior Principal, Healthcare VC
|
Senior Principal, Healthcare VC | Total investments: 11 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| AI agents for modern health systems | $25M / Series B / Jul 16, 2026 | ||
| Adaptive Innovations is the AI-native healthcare provider rebuilding the way care is delivered in America, starting with home health. | $50M / Series A / Jun 02, 2026 | ||
| AI as diverse as you. Amigo’s cloning platform enables any professional to scale their expertise, preserving your uniqueness. Increase your revenue, not your hours. | $11M / Series A / Mar 10, 2026 | ||
| Chamber Cardio is a healthcare platform enhances cardiovascular health services offering panel management, financial metrics, clinical data, software support, and value-based contracting, enabling patients and healthcare sectors to receive appropriate treatment. | $60M / Series A / Feb 04, 2026 | ||
| Indigo is an insurance company that provides medical professional liability insurance to physicians and groups. Indigo uses data-driven underwriting, rapid quoting, competitive rates, and rigorous defense to offer a better insurance experience for their clients. The company was founded in 2023 and is based in Nashville, Tennessee. | $50M / Series B / Jan 29, 2026 | ||
| Gyde is an insurance technology company that operates an AI-native brokerage platform designed to support insurance professionals and agencies with digital tools and services. It provides an intelligent assistant that automates client outreach, scheduling, reminders, and routine communications to help brokers manage insurance, health, and wealthneeds. The company also offers a broker operating system that organizes meetings, captures context, and suggests cross-sell opportunities to streamline workflow. Gyde partners with agency owners through a model that integrates technology and operational support to augment traditional brokerage functions. Its platform is built to assist licensed agents in client service and administrative tasks while facilitating comprehensive advisory interactions. | Seed / Jan 28, 2026 | ||
| Gyde is an insurance technology company that operates an AI-native brokerage platform designed to support insurance professionals and agencies with digital tools and services. It provides an intelligent assistant that automates client outreach, scheduling, reminders, and routine communications to help brokers manage insurance, health, and wealthneeds. The company also offers a broker operating system that organizes meetings, captures context, and suggests cross-sell opportunities to streamline workflow. Gyde partners with agency owners through a model that integrates technology and operational support to augment traditional brokerage functions. Its platform is built to assist licensed agents in client service and administrative tasks while facilitating comprehensive advisory interactions. | $60M / Series A / Jan 28, 2026 | ||
| We exist for humanity 2Win. Pioneering BOSS [Business (Operating System) as Service]. Trusted by Top Oncologists, we serve mission critical enterprises. Transforming key operations with AI-driven discipline. Headquartered in Silicon Valley, RISA has offices across the globe. | $11.1M / Series A / Jan 13, 2026 | ||
| We aim to extend the reach of health plans, services offered through Medicare for seniors, and provider organizations in the communities they serve by enabling sophisticated value-based care programs that focus on quality improvement, and by creating access to high-quality senior primary care in markets that are struggling with physician shortages. | $20.5M / Series B / Dec 29, 2025 | ||
| Reema Health is a technology startup transforming how people navigate the gaps between health care and social care. They believe that a personalized, community-based approach to care makes it easy for anyone to access the things they need to make their lives better. | $19M / Series B / Dec 02, 2025 | ||
| See all 119 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Optum Ventures invest in?
Optum Ventures invests primarily in Health Care, Medical and Wellness startups, most often at Series A and Series B stage. Most of the 119 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Optum Ventures's check size?
Optum Ventures typically joins rounds of $8M–$38M at Series A, $15M–$67M at Series B and $25M–$140M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Optum Ventures participates in.
How do I contact Optum Ventures?
Public channels for Optum Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Optum Ventures?
The team at Optum Ventures includes Richie Chaikof (Principal), Alessandro Guazzi (Healthcare Venture Capital) and Heather Roxborough (Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
